ArticleProceedings (Baylor University. Medical Center)2018

Dramatic response to cyclin D-dependent kinase 4/6 inhibitor in refractory poorly differentiated neuroendocrine carcinoma of the breast.

Allison Shanks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.